Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro

Journal of Alzheimer's Disease : JAD
Ning LiuXiaoying Wang

Abstract

Neuroglobin (Ngb) has been reported to be increased in early and moderately advanced Alzheimer's disease (AD) stages but declined in the severe stage. However, its regulatory mechanisms and pathophysiological roles in the disease remain to be defined. In this study, we found that Ngb expression was significantly upregulated by low dose Aβ25-35, the neurotoxic fragment of Aβ1 - 40 and Aβ1 - 42, but was not further increased by a higher dose of Aβ25-35. Mutation analysis and supershift assay demonstrated that transcription factor Nuclear Factor κB (NFκB), κB2 and κB3 sites located in mouse Ngb promoter region were involved in dynamic regulation of Ngb expression in response to different doses of Aβ25-35 stimulation. In addition, we found that suppression of endogenous Ngb expression exacerbated Aβ25-35-induced neuronal cell death and mitochondrial dysfunction. Our results indicate that endogenous Ngb expression may be upregulated by low dose Aβ25-35, which is responsible for protecting against Aβ25-35-mediated neurotoxicity. These experimental findings suggest that upregulation of endogenous Ngb expression might be an effective intervention approach for AD.

References

Feb 1, 1995·Molecular Neurobiology·C W Cotman, A J Anderson
Oct 1, 1996·Brain Pathology·C W Cotman, J H Su
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·B KaltschmidtC Kaltschmidt
Oct 12, 2000·Nature·T BurmesterT Hankeln
Oct 21, 2000·Mechanisms of Ageing and Development·N MarínF J Romero
Dec 14, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y SunD A Greenberg
Dec 14, 2004·Cell Death and Differentiation·H KadowakiH Ichijo
Jun 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Maurizio BrunoriBeatrice Vallone
Oct 6, 2007·Journal of Alzheimer's Disease : JAD·John Xi Chen, Shi Du Yan
Oct 19, 2007·Current Opinion in Pharmacology·David A GreenbergAdil A Khan
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Adil A KhanDavid A Greenberg
Nov 24, 2007·Neuroscience Letters·Kunlin JinDavid A Greenberg
Jan 17, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Adil A KhanDavid A Greenberg
Apr 12, 2008·Stroke; a Journal of Cerebral Circulation·Xiaoying WangEng H Lo
Nov 18, 2008·Neurobiology of Aging·Megan SzymanskiDimitrios Avramopoulos
Jan 22, 2009·Journal of Neurochemistry·Thi Thuy Hong DuongHugh Hamlyn Harris
Jan 14, 2012·The Biochemical Journal·Ning LiuXiaoying Wang
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Christian HaassSangram Sisodia
May 8, 2013·Journal of Alzheimer's Disease : JAD·Fen SunKunlin Jin
Mar 27, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Diana L Castillo-CarranzaRakez Kayed
Jun 5, 2015·Frontiers in Neurology·Annamaria LanzillottaMarina Pizzi
Jan 7, 2016·Frontiers in Molecular Neuroscience·Ruey-Horng ShihChuen-Mao Yang
Mar 22, 2016·CNS & Neurological Disorders Drug Targets·Ning LiuXiaoying Wang
Dec 14, 2016·Molecular Neurobiology·Maria Teresa NuzzoMaria Marino
Oct 19, 2017·Journal of Alzheimer's Disease : JAD·Russell H Swerdlow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Lower Grade Glioma

Low grade gliomas in the brain form from oligodendrocytes and astrocytes and are the slowest-growing glioma in adults. Discover the latest research on these brain tumors here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.